These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26016790)

  • 81. Cancer Screening: Patient and Population Strategies.
    Lane DS; Smith RA
    Med Clin North Am; 2023 Nov; 107(6):989-999. PubMed ID: 37806730
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cancer screening in Spain.
    Ascunce N; Salas D; Zubizarreta R; Almazán R; Ibáñez J; Ederra M;
    Ann Oncol; 2010 May; 21 Suppl 3():iii43-51. PubMed ID: 20427360
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Breast cancer screening: CNGOF gets mobilized].
    Mathelin C; Nisand I
    Gynecol Obstet Fertil Senol; 2018 Jun; 46(6):507-508. PubMed ID: 29776840
    [No Abstract]   [Full Text] [Related]  

  • 84. Trends in Metastatic Breast and Prostate Cancer.
    Fouad TM
    N Engl J Med; 2016 Feb; 374(6):595. PubMed ID: 26863371
    [No Abstract]   [Full Text] [Related]  

  • 85. Trends in Metastatic Breast and Prostate Cancer.
    Eby PR
    N Engl J Med; 2016 Feb; 374(6):595. PubMed ID: 26863370
    [No Abstract]   [Full Text] [Related]  

  • 86. Trends in Metastatic Breast and Prostate Cancer.
    Gaylis FD; Choi J; Kader AK
    N Engl J Med; 2016 Feb; 374(6):594-5. PubMed ID: 26863369
    [No Abstract]   [Full Text] [Related]  

  • 87. Trends in Metastatic Breast and Prostate Cancer.
    Welch HG; Gorski DH; Albertsen PC
    N Engl J Med; 2016 Feb; 374(6):596. PubMed ID: 26863368
    [No Abstract]   [Full Text] [Related]  

  • 88. Awareness and Misconceptions of Breast Cancer Risk Factors Among Laypersons and Physicians.
    Morère JF; Viguier J; Couraud S; Brignoli-Guibaudet L; Lhomel C; Pivot XB; Eisinger F
    Curr Oncol Rep; 2018 Mar; 20(Suppl 1):15. PubMed ID: 29508148
    [TBL] [Abstract][Full Text] [Related]  

  • 89. ASO Author Reflections: Association of Community Economic Distress and Breast and Colorectal Cancer Screening, Incidence, and Mortality Rates among U.S. Counties.
    Herbert C; Paro A; Diaz A; Pawlik TM
    Ann Surg Oncol; 2022 Feb; 29(2):849-850. PubMed ID: 34599435
    [No Abstract]   [Full Text] [Related]  

  • 90. Refinement of the Target Population for Colorectal Cancer Screening in France, Inventory as a Prelude to the Use of Medico-Administrative Database.
    Koïvogui A; Benamouzig R; Duclos C
    Stud Health Technol Inform; 2023 May; 302():394-395. PubMed ID: 37203702
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Author's reply to: Implementation and organization of cancer screening in France.
    Basu P; Ponti A; Anttila A; Ronco G; Senore C; Vale DB; Segnan N; Tomatis M; Soerjomataram I; Žakelj MP; Dillner J; Elfström KM; Lönnberg S; Sankaranarayanan R
    Int J Cancer; 2018 Dec; 143(11):3035. PubMed ID: 29943811
    [No Abstract]   [Full Text] [Related]  

  • 92. Medical education: edifice or edification.
    Neelands PJ
    Can Med Assoc J; 1976 Sep; 115(5):391. PubMed ID: 20312777
    [No Abstract]   [Full Text] [Related]  

  • 93. Medical education: edifice or edification.
    Thompson WG
    Can Med Assoc J; 1976 Sep; 115(5):391. PubMed ID: 20312775
    [No Abstract]   [Full Text] [Related]  

  • 94. The College Edifice, &c.
    Atlanta Med Surg J; 1857 Feb; 2(6):374-375. PubMed ID: 35825308
    [No Abstract]   [Full Text] [Related]  

  • 95. Future perspectives for cancer screening.
    Viguier J
    Eur J Cancer Prev; 2015 Jun; 24 Suppl():S87-9. PubMed ID: 26016794
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Colonoscopy screening for colorectal cancer in Egypt: a nationwide cross-sectional study.
    Allam AR; Elsayed MA; Daghash IT; Abdelaziz AM; Mostafa OM; Sabra HK; Eldaboush AM; Ahmed NMB; Elweza RT; Adwy ES; Hammad AE; Kabbash IA; Allam AH; Bahbah AA; Ewis MI; Mohamed Shawqi M; Behery MB; Mohamed El-Said Y; Radwan AE; KhallafAllah MT; Aboshady OA; Gouda MA
    BMC Cancer; 2024 Jan; 24(1):131. PubMed ID: 38273265
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Colon Cancer Screening Programs: Impact of an Organized Screening Strategy Assessed by the EDIFICE Surveys.
    Viguier J; Morère JF; Brignoli-Guibaudet L; Lhomel C; Couraud S; Eisinger F
    Curr Oncol Rep; 2018 Mar; 20(Suppl 1):16. PubMed ID: 29508157
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Fluctuating Behavior of the French Population in Cancer Screening: 5th Edition of the EDIFICE Survey.
    Viguier J; Morère JF; Pivot X; Touboul C; Lhomel C; Couraud S; de La Motte Rouge T; Eisinger F
    Curr Oncol Rep; 2018 Mar; 20(Suppl 1):14. PubMed ID: 29508088
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Cancer screening in France: third edition of the EDIFICE survey.
    Viguier J; Morère JF; Touboul C; Coscas Y; Blay JY; Lhomel C; Pivot X; Eisinger F
    Eur J Cancer Prev; 2015 Jun; 24 Suppl():S68-72. PubMed ID: 26016790
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Breast cancer screening controversy: too much or not enough?
    Pivot X; Viguier J; Touboul C; Morère JF; Blay JY; Coscas Y; Lhomel C; Eisinger F
    Eur J Cancer Prev; 2015 Jun; 24 Suppl():S73-6. PubMed ID: 26016791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.